PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Berlin Cures GmbH, Robert-Rössle-Str. 10 Blg. D79, 13125 Berlin, Germany.\', \'Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Robert-Rössle-Str. 10, 13125 Berlin, Germany.\', \'Berlin Cures GmbH, Knesebeckstr. 59-61, 10719 Berlin, Germany.\', \'Department of Chemistry, NMR Facility, Humboldt University of Berlin, Brook-Taylor-Straße 2, 12489 Berlin, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 93210.3390/v13050932
?:hasPublicationType
?:journal
  • Viruses
is ?:pmid of
?:pmid
?:pmid
  • 34069827
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.805
?:rankingScore_hIndex
  • 52
is ?:relation_isRelatedTo_publication of
?:title
  • Aptamer BC 007\'s Affinity to Specific and Less-Specific Anti-SARS-CoV-2 Neutralizing Antibodies.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34069827>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34069827>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all